CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles

Mucosal Immunology

Volumn 2, Issue 6, 2009, Pages 486-494

  Marchesi, F ^a   Martin, A P ^a   Thirunarayanan, N ^a   Devany, E ^a   Mayer, L ^a   Grisotto, M G ^a   Furtado, G C ^a   Lira, S A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; INTERLEUKIN 22; INTERLEUKIN 23 RECEPTOR; LYMPHOTOXIN; LYMPHOTOXIN BETA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P46; RETINOIC ACID RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SIZE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INTESTINE; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LYMPH FOLLICLE; LYMPHANGIOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE INDUCER CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMALL INTESTINE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

EID: 70350649131     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.113     Document Type: Article

References (61)

1. Eberl, G. Inducible lymphoid tissues in the adult gut: Recapitulation of a fetal developmental pathway? Nat. Rev. Immunol. 5, 413-420 (2005).
2. Forster, R., Pabst, O. & Bernhardt, G. Homeostatic chemokines in development, plasticity, and functional organization of the intestinal immune system. Semin. Immunol. 20, 171-180 (2008).
3. Newberry, R.D. & Lorenz, R.G. Organizing a mucosal defense. Immunol. Rev. 206, 6-21 (2005).
4. Brandtzaeg, P., Kiyono, H., Pabst, R. & Russell, M.W. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal. Immunol. 1, 31-37 (2008).
5. Pabst, O. et al. Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling. J. Immunol. 177, 6824-6832 (2006).
6. Lugering, A. & Kucharzik, T. Induction of intestinal lymphoid tissue: the role of cryptopatches. Ann. N. Y. Acad. Sci. 1072, 210-217 (2006).
7. Newberry, R.D., McDonough, J.S., McDonald, K.G. & Lorenz, R.G. Postgestational lymphotoxin/lymphotoxin beta receptor interactions are essential for the presence of intestinal B lymphocytes. J. Immunol. 168, 4988-4997 (2002).
8. Pabst, O. et al. Cryptopatches and Isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur. J. Immunol. 35, 98-107 (2005).
9. Lorenz, R.G. & Newberry, R.D. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann. N. Y. Acad. Sci. 1029, 44-57 (2004).
10. Hamada, H. et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol. 168, 57--64 (2002).
11. Tsuji, M. et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29, 261-271 (2008).
12. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008).
13. Fagarasan, S. et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298, 1424-1427 (2002).
14. Lorenz, R.G., Chaplin, D.D., McDonald, K.G., McDonough, J.S. & Newberry, R.D. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J. Immunol. 170, 5475-5482 (2003).
15. Eberl, G. & Littman, D.R. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgamma t+ cells. Science 305, 248-251 (2004).
16. McDonald, K.G., McDonough, J.S. & Newberry, R.D. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J. Immunol. 174, 5720-5728 (2005).
17. Varona, R. et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107, R37-45 (2001).
18. McDonald, K.G. et al. CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles. Am. J. Pathol. 170, 1229-1240 (2007).
19. Ansel, K.M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314 (2000).
20. Velaga, S. et al. Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses. J. Immunol. 182, 2610-2619 (2009).
21. Okada, T. et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196, 65-75 (2002).
22. Warnock, R.A. et al. The role of chemokines in the microenvironmental control of T vs. B cell arrest in Peyer's patch high endothelial venules. J. Exp. Med. 191, 77-88 (2000).
23. Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99, 23-33 (1999).
24. Drayton, D.L., Liao, S., Mounzer, R.H. & Ruddle, N.H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7, 344-353 (2006).
25. Mebius, R.E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3, 292-303 (2003).
26. Mebius, R.E., Rennert, P. & Weissman, I.L. Developing lymph nodes collect CD4+CD3 - LTbeta+cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
27. Heller, F. et al. The contribution of B cells to renal interstitial inflammation. Am. J. Pathol. 170, 457-468 (2007).
28. Aloisi, F. et al. Lymphoid chemokines in chronic neuroinflammation. J. Neuroimmunol. 198, 106-112 (2008).
29. Barone, F. et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis. Rheum. 52, 1773-1784 (2005).
30. Aust, G. et al. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur. J. Endocrinol. 150, 225-234 (2004).
31. Le Panse, R. et al. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis. Ann. N. Y. Acad. Sci. 1132, 135-142 (2008).
32. Vermi, W. et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 107 454-462 (2006).
33. Luther, S.A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471-481 (2000).
34. Martin, A.P., Canasto-Chibuque, C., Shang, L., Rollins, B.J. & Lira, S.A. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J. Immunol. 177, 7296-7302 (2006).
35. Shang, L. et al. Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine. Gastroenterology (2009). (In press).
36. Abad, C. et al. cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP. Inflamm. Bowel. Dis. 11, 674-684 (2005).
37. Carlsen, H.S., Baekkevold, E.S., Johansen, F.E., Haraldsen, G. & Brandtzaeg, P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut. 51, 364-371 (2002).
38. Mazzucchelli, L. et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104, R49-54 (1999).
39. Galamb, O. et al. Helicobacter pylori and antrum erosion-specific gene expression patterns: The discriminative role of CXCL13 and VCAM1 transcripts. Helicobacter 13, 112-126 (2008).
40. Hofman, V.J. et al. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod. Pathol. 20, 974-989 (2007).
41. Pinto, D., Robine, S., Jaisser, F., El Marjou, F.E. & Louvard, D. Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J. Biol. Chem. 274, 6476-6482 (1999).
42. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
43. Luci, C. et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
44. Sanos, S.L. et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
45. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
46. Zheng, Y. et. al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 648-651 (2007).
47. Kanamori, Y. et al. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J. Exp. Med. 184, 1449-1459 (1996).
48. Luther, S.A., Ansel, K.M. & Cyster, J.G. Ovarlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J. Exp. Med. 197, 1191-11 98 (2003).
49. Marinkovic, T. et al. Interaction of mature CD3+CD4+T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Invest. 116, 2622-2632 (2006).
50. Furtado, G.C. et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc. Natl. Acad. Sci. USA 104, 5026-5031 (2007).
51. Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
52. Kastelein, R.A., Hunter, C.A. & Cua, D.J. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221-242 (2007).
53. Zenewicz, L.A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
54. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004).
55. Aujla, S.J. et al. IL-22 mediates mucosal heat defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 276-281 (2008).
56. Ouyang, W., Kolls, J.K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467 (2008).
57. Honda, K. et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193, 621-630 (2001).
58. Lugering, A. et al. Lymphoid precursos in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J. Immunol. 171, 2208-2215 (2003).
59. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812 (2007).
60. Eberl, G. & Littman, D.R. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195, 81-90 (2003).
61. Lefrancois, L., Barrett, T.A., Havran, W.L. & Puddington, L. Developmental expression of the alpha IEL beta 7 integrin on T cell receptor gamma delta and T cell receptor alpha beta T cells. Eur. J. Immunol. 24, 635-640 (1994).